Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lung Neoplasms 11Breast Neoplasms 11Prostatic Neoplasms 7Colorectal Neoplasms 7Pancreatic Neoplasms 3Ovarian Neoplasms 3Lymphoma 3Advanced Malignant Solid Neoplasm 3Skin Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Obesity-Related Malignant Neoplasm 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Malignant Solid Neoplasm 2Leukemia, Myeloid, Acute 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Anatomic Stage I Breast Cancer AJCC v8 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Syndrome 1Substance-Related Disorders 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Psoriasis 1Primary Myelofibrosis 1

Interventions

Ultrasonic Waves 1Tobacco Use Cessation Devices 1Nicotine Replacement Therapy 1Nicotine Chewing Gum 1Ethanol 1Educational Status 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Substance-Related Disorders × Educational Status × 90 days × Clear all
NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡